{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:08:45Z","timestamp":1789229325091,"version":"build-2803163510"},"reference-count":31,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2023,7,29]]},"DOI":"10.1536\/ihj.22-553","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T22:15:30Z","timestamp":1689286530000},"page":"724-731","source":"Crossref","is-referenced-by-count":4,"title":["Substernal Extravascular Implantable Cardioverter-Defibrillator System Infections in Large Animals"],"prefix":"10.1536","volume":"64","author":[{"given":"Amy E.","family":"Thompson","sequence":"first","affiliation":[{"name":"Medtronic, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Christie","sequence":"additional","affiliation":[{"name":"Medtronic, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnea","family":"Lentz","sequence":"additional","affiliation":[{"name":"Medtronic, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mirowski M, Reid PR, Mower MM, <i>et al<\/i>. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303: 322-4.","DOI":"10.1056\/NEJM198008073030607"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tarakji KG, Mittal S, Kennergren C, <i>et al<\/i>. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med 2019; 380: 1895-905.","DOI":"10.1056\/NEJMoa1901111"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005; 28: 926-32.","DOI":"10.1111\/j.1540-8159.2005.00195.x"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Baddour LM, Epstein AE, Erickson CC, <i>et al<\/i>. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010; 121: 458-77.","DOI":"10.1161\/CIRCULATIONAHA.109.192665"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Weiss R, Knight BP, Gold MR, <i>et al<\/i>. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 2013; 128: 944-53.","DOI":"10.1161\/CIRCULATIONAHA.113.003042"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Knops RE, Olde Nordkamp LRA, Delnoy PHM, <i>et al<\/i>. Subcutaneous or transvenous defibrillator therapy. N Engl J Med 2020; 383: 526-36.","DOI":"10.1056\/NEJMoa1915932"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gold MR, Lambiase PD, El-Chami MF, <i>et al<\/i>. Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial. Circulation 2021; 143: 7-17.","DOI":"10.1161\/CIRCULATIONAHA.120.048728"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. van der Stuijt W, Quast ABE, Baalman SWE, Olde Nordkamp LRA, Wilde AAM, Knops RE. Improving the care for female subcutaneous ICD patients: a qualitative study of gender-specific issues. Int J Cardiol 2020; 317: 91-5.","DOI":"10.1016\/j.ijcard.2020.05.091"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Boersma L, Barr C, Knops R, <i>et al<\/i>. Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol 2017; 70: 830-41.","DOI":"10.1016\/j.jacc.2017.06.040"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Burke MC, Gold MR, Knight BP, <i>et al<\/i>. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry. J Am Coll Cardiol 2015; 65: 1605-15.","DOI":"10.1016\/j.jacc.2015.02.047"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Brouwer TF, Yilmaz D, Lindeboom R, <i>et al<\/i>. Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy. J Am Coll Cardiol 2016; 68: 2047-55.","DOI":"10.1016\/j.jacc.2016.08.044"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Theuns DAMJ, Crozier IG, Barr CS, <i>et al<\/i>. Longevity of the subcutaneous implantable defibrillator: long-term follow-up of the European regulatory trial cohort. Circ Arrhythm Electrophysiol 2015; 8: 1159-63.","DOI":"10.1161\/CIRCEP.115.002953"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chan JYS, Lelakowski J, Murgatroyd FD, <i>et al<\/i>. Novel extravascular defibrillation configuration with a coil in the substernal space: the ASD clinical study. JACC Clin Electrophysiol 2017; 3: 905-10.","DOI":"10.1016\/j.jacep.2016.12.026"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Sholevar DP, Tung S, Kuriachan V, <i>et al<\/i>. Feasibility of extravascular pacing with a novel substernal electrode configuration: the Substernal Pacing Acute Clinical Evaluation study. Heart Rhythm 2018; 15: 536-42.","DOI":"10.1016\/j.hrthm.2017.11.030"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Boersma LVA, Merkely B, Neuzil P, <i>et al<\/i>. Therapy from a novel substernal lead: the ASD2 study. JACC Clin Electrophysiol 2019; 5: 186-96.","DOI":"10.1016\/j.jacep.2018.11.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Crozier I, Haqqani H, Kotschet E, <i>et al<\/i>. First-in-human chronic implant experience of the substernal extravascular implantable cardioverter-defibrillator. JACC Clin Electrophysiol 2020; 6: 1525-36.","DOI":"10.1016\/j.jacep.2020.05.029"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Crozier I, O&apos;Donnell D, Boersma L, <i>et al<\/i>. The extravascular implantable cardioverter-defibrillator: the pivotal study plan. J Cardiovasc Electrophysiol 2021; 32: 2371-8.","DOI":"10.1111\/jce.15190"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Thompson AE, Atwater B, Boersma LVA, <i>et al<\/i>. The development of the extravascular defibrillator with substernal lead placement: a new frontier for device-based treatment of sudden cardiac arrest. J Cardiovasc Electrophysiol 2022; 33: 1085-95.","DOI":"10.1111\/jce.15511"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Friedman P, Murgatroyd F, Boersma LVA, <i>et al<\/i>. Efficacy and safety of an extravascular implantable cardioverter-defibrillator. N Engl J Med 2022; 387: 1292-302.","DOI":"10.1056\/NEJMoa2206485"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hu QL, Ko CY. Prevention of Perioperative Surgical Site Infection. <i>Perioperative Medicine<\/i>. 2nd ed. Philadelphia, Pennsylvania: Elsevier; 2022: 444-57.","DOI":"10.1016\/B978-0-323-56724-4.00028-9"},{"key":"21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/europace\/euab243","volume":"24","year":"2022","unstructured":"21. Moln\u00e1r L, Crozier I, Haqqani H, <i>et al<\/i>. The extravascular implantable cardioverter-defibrillator: characterization of anatomical parameters impacting substernal implantation and defibrillation efficacy. Europace 2022; 24: 762-73.","journal-title":"Europace","ISSN":"https:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Fanning WJ, Vasko JS, Kilman JW. Delayed sternal closure after cardiac surgery. Ann Thorac Surg 1987; 44: 169-72.","DOI":"10.1016\/S0003-4975(10)62034-6"},{"key":"23","unstructured":"23. Choi JB, Yang HW, Han JO, Choi SH. Manubrium-sparing median sternotomy as a uniform approach for cardiac operations. Tex Heart Inst J 2000; 27: 32-6; discussion 37."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Singh K, Anderson E, Harper JG. Overview and management of sternal wound infection. Semin Plast Surg 2011; 25: 25-33.","DOI":"10.1055\/s-0031-1275168"},{"key":"25","unstructured":"25. Guden M, Korkmaz AA, Onan B, Onan IS, Tarakci SI, Fidan F. Subxiphoid versus intercostal chest tubes: comparison of postoperative pain and pulmonary morbidities after coronary artery bypass grafting. Tex Heart Inst J 2012; 39: 507-12."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nuss D. Recent experiences with minimally invasive pectus excavatum repair &quot;Nuss procedure&quot; . Jpn J Thorac Cardiovasc Surg 2005; 53: 338-44.","DOI":"10.1007\/s11748-005-0047-1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kelly RE, Goretsky MJ, Obermeyer R, <i>et al<\/i>. Twenty-one years of experience with minimally invasive repair of pectus excavatum by the Nuss procedure in 1215 patients. Ann Surg 2010; 252: 1072-81.","DOI":"10.1097\/SLA.0b013e3181effdce"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Obermeyer RJ, Godbout E, Goretsky MJ, <i>et al<\/i>. Risk factors and management of Nuss bar infections in 1717 patients over 25 years. J Pediatr Surg 2016; 51: 154-8.","DOI":"10.1016\/j.jpedsurg.2015.10.036"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Martin C, Viviand X, Alaya M, <i>et al<\/i>. Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans. Antimicrob Agents Chemother 1996; 40: 812-5.","DOI":"10.1128\/AAC.40.3.812"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Martin C, Bourget P, Alaya M, <i>et al<\/i>. Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues. Antimicrob Agents Chemother 1997; 41: 1150-5.","DOI":"10.1128\/AAC.41.5.1150"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Martin C, Alaya M, Mallet MN, <i>et al<\/i>. Penetration of vancomycin into mediastinal and cardiac tissues in humans. Antimicrob Agents Chemother 1994; 38: 396-9.","DOI":"10.1128\/AAC.38.2.396"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/4\/64_22-553\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T04:03:05Z","timestamp":1690603385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/4\/64_22-553\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.22-553","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,29]]},"article-number":"22-553"}}